Biotech thrill is gone as virus ebbs
The first year of the covid-19 pandemic fueled a frenzy for biotechnology stocks. Now, with vaccines in millions of arms and the omicron variant on the wane, there are signs investors are ready to move on.
Source: arkansasonline.com
